Search - tctmd.com

Displaying 581 - 600 of 603

Sort: Relevancy | Date

News Daily News

Mode of Revascularization Influenced by Angiographer, Hospital ‘Culture’

March 06, 2012

News Daily News

BRIDGE Published: Cangrelor Promising Option as Bridging Therapy

January 16, 2012

News Daily News

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

Jason Kahn

January 08, 2012

News Daily News

Clopidogrel Prescriptions Not Being Filled Fast Enough, If at All

Yael L. Maxwell

December 14, 2011

News Daily News

Same-Day Discharge Does Not Affect Death, Rehospitalization Risk After PCI

L.A. McKeown

October 04, 2011

News Daily News

Rivaroxaban Continues Emergence of New Class of Anticoagulants for A-Fib

Caitlin E. Cox

September 14, 2011

News Conference News

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

August 31, 2011

News Conference News

Apixaban Bests Warfarin in Stroke Prevention for Atrial Fib

August 28, 2011

News Daily News

CT Perfusion Imaging Captures Anatomy, Function

Caitlin E. Cox

August 24, 2011

News Daily News

ROCKET AF Published: Rivaroxaban Matches Warfarin in Treating A-Fib Patients

Caitlin E. Cox

August 10, 2011

News Daily News

Women Have Less Neointimal Hyperplasia Than Men With ZES

Leah Lawrence

July 29, 2011

News Daily News

After Gravitas Part 2: Is There a Future for Functional Platelet Testing?

July 25, 2011

News Daily News

Ticagrelor Gains FDA Approval for Use in ACS

Caitlin E. Cox

July 22, 2011

News Daily News

Local-Regional Anesthesia Better Than General for EVAR

L.A. McKeown

July 22, 2011

News Daily News

Genetic Variant Predicts Revascularization, Disease Progression in Young MI Patients

July 13, 2011

News Daily News

IVUS Criterion a Safe Guide to Deferral of Left Main Intervention

July 11, 2011

News Daily News

Adding Omega-3 Fatty Acids to Dual Antiplatelet Therapy May Reduce Thrombotic Risk

Leah Lawrence

May 26, 2011

News Daily News

Lack of Benefit, Potential Harm REVEALed with EPO in STEMI Patients

Jason Kahn

May 12, 2011

News Daily News

Elderly STEMI Patients Face Poorer Outcomes After Primary PCI

Caitlin E. Cox

April 20, 2011

News Daily News

Cilostazol Reduces Repeat Revascularizations for Long Lesions

March 06, 2011

Advertisement

Mode of Revascularization Influenced by Angiographer, Hospital ‘Culture’

BRIDGE Published: Cangrelor Promising Option as Bridging Therapy

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

Clopidogrel Prescriptions Not Being Filled Fast Enough, If at All

Same-Day Discharge Does Not Affect Death, Rehospitalization Risk After PCI

Rivaroxaban Continues Emergence of New Class of Anticoagulants for A-Fib

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

Apixaban Bests Warfarin in Stroke Prevention for Atrial Fib

CT Perfusion Imaging Captures Anatomy, Function

ROCKET AF Published: Rivaroxaban Matches Warfarin in Treating A-Fib Patients

Women Have Less Neointimal Hyperplasia Than Men With ZES

After Gravitas Part 2: Is There a Future for Functional Platelet Testing?

Ticagrelor Gains FDA Approval for Use in ACS

Local-Regional Anesthesia Better Than General for EVAR

Genetic Variant Predicts Revascularization, Disease Progression in Young MI Patients

IVUS Criterion a Safe Guide to Deferral of Left Main Intervention

Adding Omega-3 Fatty Acids to Dual Antiplatelet Therapy May Reduce Thrombotic Risk

Lack of Benefit, Potential Harm REVEALed with EPO in STEMI Patients

Elderly STEMI Patients Face Poorer Outcomes After Primary PCI

Cilostazol Reduces Repeat Revascularizations for Long Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content